Featured

COPD

Traveling by Airplane With COPD: Expert Advice

Traveling by Airplane With COPD: Expert Advice

Healthcare providers should educate all patients with COPD about their flight-related risks and the need to seek medical advice before flying.

Latest

Inflammatory Markers in COPD Linked to Increased Symptom Burden in Smokers

Inflammatory Markers in COPD Linked to Increased Symptom Burden in Smokers

Inflammatory markers associated with COPD were linked to increased symptom burden, a greater number of exacerbations, and decreased 6-minute walk distance in smokers with preserved spirometry.

Advair Diskus Generic Now Available for COPD and Asthma

Advair Diskus Generic Now Available for COPD and Asthma

Wixela Inhub has been made available by Mylan for the treatment of asthma and COPD.

Comprehensive Research Bronchoscopy Procedure Safe, Tolerable in COPD

Comprehensive Research Bronchoscopy Procedure Safe, Tolerable in COPD

A comprehensive research bronchoscopy procedure, including oral sampling, bronchoalveolar lavage, endobronchial biopsy, and brushing can be safely performed in COPD.

Triple Therapy Reduces COPD Exacerbation Risk Compared With Dual Therapy

Triple Therapy Reduces COPD Exacerbation Risk Compared With Dual Therapy

Compared with dual therapy, triple therapy was associated with reduced risk for severe exacerbation of COPD and better FEV1.

First Generic Version of Advair Diskus Gets FDA Approval

First Generic Version of Advair Diskus Gets FDA Approval

Mylan plans to make Wixela Inhub available in 3 strengths: 100mcg/50mcg, 250mcg/50mcg, and 500mcg/50mcg.

COPD Common Condition in Frequent Users of Emergency Department

COPD Common Condition in Frequent Users of Emergency Department

Nearly 6% of older adults account for more than 20% of emergency department visits.

Indacaterol/Glycopyrronium Improves Regional Ventilation in COPD

Indacaterol/Glycopyrronium Improves Regional Ventilation in COPD

In patients with moderate to severe COPD, indacaterol/glycopyrronium treatment is associated with improvements in regional ventilation and pulmonary microvascular blood flow.

DASS-21 Demonstrates Validity, Responsiveness in COPD

DASS-21 Demonstrates Validity, Responsiveness in COPD

The Depression, Anxiety, and Stress Scale (DASS-21) demonstrated validity in individuals with COPD underwent an 8-week pulmonary rehabilitation program.

COPD Exacerbations May Be Reduced With Vitamin D

COPD Exacerbations May Be Reduced With Vitamin D

The review showed supplementation was only effective for baseline vitamin D levels <25 nmol/L.

Cardiovascular Comorbidity Screening Should Be Conducted in COPD With Obesity

Cardiovascular Comorbidity Screening Should Be Conducted in COPD With Obesity

Hypertension and diabetes are especially prevalent comorbidities in obese patients with chronic obstructive pulmonary disease.

Influenza Vaccine Cuts Flu-Related Hospitalization in COPD

Influenza Vaccine Cuts Flu-Related Hospitalization in COPD

Influenza-positive patients have higher rates of crude mortality and critical illness vs influenza-negative patients.

Hypercapnic COPD Survival, Clinical Outcomes With High-Intensity NIV

Hypercapnic COPD Survival, Clinical Outcomes With High-Intensity NIV

Patients with comorbid stable COPD and chronic hypercapnic respiratory failure have improved symptoms and survival rates with high-intensity noninvasive ventilation.

Keeping Up-to-Date on COPD Controversies: A Clinician Interview

Keeping Up-to-Date on COPD Controversies: A Clinician Interview

The GOLD scientific committee published a report on current controversies in COPD, including the role of cigarette smoking vs biomass exposure, the role of thoracic imaging, and different treatment strategies.

COPD Assessment Test May Help Determine Severity of Bronchiectasis

COPD Assessment Test May Help Determine Severity of Bronchiectasis

The COPD assessment test proved to be valid and reproducible in assessing the impact effect and severity of bronchiectasis symptoms in patients with COPD.

COPD and Obesity: Is There a Dose-Response Relationship in Nonsmokers?

COPD and Obesity: Is There a Dose-Response Relationship in Nonsmokers?

The odds of developing COPD were considerably higher in both men and women with class III obesity compared with normal weight individuals.

Anxiety in COPD Benefits From Cognitive Behavioral Therapy vs Self-Help

Anxiety in COPD Benefits From Cognitive Behavioral Therapy vs Self-Help

Cognitive behavioral therapy interventions were statistically and clinically superior to self-help leaflets in the treatment of anxiety in patients with COPD.

Frailty Linked to Poor Health Outcomes in COPD

Frailty Linked to Poor Health Outcomes in COPD

Patients with COPD who were considered frail were more likely to have lower quality of life, increased rate and length of hospitalization, and a higher rate of mortality.

Self-Management Support Improves Quality of Life in COPD

Self-Management Support Improves Quality of Life in COPD

Compared with usual care, a comprehensive 3-month program combining transition and long-term self-management support for patients with COPD led to significantly fewer COPD-related hospitalizations and greater quality of life.

COPD Tied to Obesity in Never-Smokers

COPD Tied to Obesity in Never-Smokers

A strong dose-response relationship was seen in never-smokers aged 50 and older.

Sign Up for Free e-newsletters